Patients in the U.S. who can prove they lost their healthcare benefits because of a job termination notice or job status change are eligible. In addition, the offer will be extended past 90 days for anyone who is denied Medicaid benefits.
“The pandemic is taking a serious toll on the nation’s health and economy. Millions of people are losing jobs and health coverage, and that’s especially tragic if you have a chronic disease like diabetes,” said Doug Langa, executive vice president of Novo Nordisk’s North America operations and president of Novo Nordisk. “Patients have enough issues to worry about at this moment. We don’t want being able to pay for their insulin to be one of them.”
Novo Nordisk’s plan for more affordable insulin follows a similar move that Eli Lilly took last week, which capped out-of-pocket costs for insulin at $35 a month.
More articles on pharmacy:
Death penalty states hoarding drugs needed to ventilate COVID-19 patients
UnitedHealthcare to pay Ohio pharmacists as medical providers
Purdue University grants early graduation to 144 pharmacy students
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
